Evidence map›Paper›PMID 35228581›Full record

ArticleScientific reports2022

External quality assessment of HIV-1 DNA quantification assays used in the clinical setting in Italy.

Ilaria Vicenti, Filippo Dragoni, Alessia Giannini, Anna Casabianca, Francesca Lombardi, Laura Di Sante, Ombretta Turriziani, Sara Racca, Stefania Paolucci, Alessia Lai and 9 more

Abstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Validation of digital droplet PCR assays for cell-associated HIV-1 DNA, HIV-1 2-LTR circle, and HIV-1 unspliced RNA for clinical studies in HIV-1 cure research.Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology · 2024
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Ilaria VicentiDepartment of Medical Biotechnologies, University of Siena, Siena, Italy. vicenti@unisi.it.
Filippo DragoniDepartment of Medical Biotechnologies, University of Siena, Siena, Italy.
Alessia GianniniDepartment of Medical Biotechnologies, University of Siena, Siena, Italy.
Anna CasabiancaDepartment of Biomolecular Sciences, University of Urbino "Carlo Bo", Urbino, PU, Italy.
Francesca LombardiFondazione Policlinico Universitario A. Gemelli IRCCS, UOC Malattie Infettive, Rome, Italy.
Laura Di SanteVirology Unit, Department of Biomedical Sciences and Public Health, Polytechnic University of Marche, Ancona, Italy.
Ombretta TurrizianiDepartment of Molecular Medicine, Sapienza University of Rome, Rome, Italy.
Sara RaccaLaboratory of Microbiology and Virology, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Stefania PaolucciMolecular Virology Unit, Microbiology and Virology Department, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
Alessia LaiDepartment of Biomedical and Clinical Sciences Luigi Sacco, University of Milan, Milan, Italy.
Isabella BonUO Microbiologia, IRCSS Azienda Ospedaliero Universitaria di Bologna, Policlinico S. Orsola, Bologna, Italy.
Isabella AbbateVirology and Biosafety Laboratories Unit, National Institute for Infectious Diseases IRCCS L. Spallanzani, Rome, Italy.
Gabriella RozeraVirology and Biosafety Laboratories Unit, National Institute for Infectious Diseases IRCCS L. Spallanzani, Rome, Italy.
Simone BelmontiDipartimento di Sicurezza e Bioetica, Sezione Malattie Infettive, Università Cattolica del Sacro Cuore, Rome, Italy.
Rossana ScutariDepartment of Experimental Medicine, University of Rome "Tor Vergata", Rome, Italy.
Claudia AlteriDepartment of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
Francesco SaladiniDepartment of Medical Biotechnologies, University of Siena, Siena, Italy.
Maurizio ZazziDepartment of Medical Biotechnologies, University of Siena, Siena, Italy.
Italian HIV DNA Network

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Total cell-associated HIV-1 DNA is a surrogate marker of the HIV-1 reservoir, however, certified systems for its quantification are not available. The Italian HIV DNA Network was launched to validate HIV-1 DNA quantification methods in use at University and Hospital labs. A quality control panel including HIV-1 DNA standards, reconstructed blood samples (RBSs) and DNA from different HIV-1 subtypes was blindly tested by 12 participating labs by quantitative real-time PCR (n = 6), droplet digital PCR (n = 3) or both (n = 3). The median 95% hit rate was 4.6 (3.7-5.5) copies per test and linearity in the tested range was excellent (R

Indexed as

HIV-1HIV InfectionsHumansItalyReal-Time Polymerase Chain Reaction

Identifiers

PMID35228581
PMCPMC8885833

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.